Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration‐resistant prostate cancer. - Fenioux, Charlotte; Louvet, Christophe; Charton, Emilie; Rozet, Francois; Ropert, Stanislas; Prapotnich, Dominique; Barret, Eric; Sanchez‐Salas, Rafael; Mombet, Annick; Cathala, Nathalie; Joulia, Marie‐Liesse; Molitor, Jean‐Luc; et al. (BJU International, 2019)